SG11202007899QA - Ultra-sensitive detection of circulating tumor dna through genome-wide integration - Google Patents

Ultra-sensitive detection of circulating tumor dna through genome-wide integration

Info

Publication number
SG11202007899QA
SG11202007899QA SG11202007899QA SG11202007899QA SG11202007899QA SG 11202007899Q A SG11202007899Q A SG 11202007899QA SG 11202007899Q A SG11202007899Q A SG 11202007899QA SG 11202007899Q A SG11202007899Q A SG 11202007899QA SG 11202007899Q A SG11202007899Q A SG 11202007899QA
Authority
SG
Singapore
Prior art keywords
genome
ultra
circulating tumor
sensitive detection
tumor dna
Prior art date
Application number
SG11202007899QA
Inventor
Dan Avi Landau
Asaf Zviran
Original Assignee
Univ Cornell
New York Genome Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cornell, New York Genome Center filed Critical Univ Cornell
Publication of SG11202007899QA publication Critical patent/SG11202007899QA/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00—Machine learning
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/08—Learning methods
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Organic Chemistry (AREA)
  • Software Systems (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Evolutionary Computation (AREA)
  • Artificial Intelligence (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Databases & Information Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioethics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Computing Systems (AREA)
  • General Physics & Mathematics (AREA)
SG11202007899QA 2018-02-27 2019-02-27 Ultra-sensitive detection of circulating tumor dna through genome-wide integration SG11202007899QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862636135P 2018-02-27 2018-02-27
PCT/US2019/019905 WO2019169042A1 (en) 2018-02-27 2019-02-27 Ultra-sensitive detection of circulating tumor dna through genome-wide integration

Publications (1)

Publication Number Publication Date
SG11202007899QA true SG11202007899QA (en) 2020-09-29

Family

ID=67806402

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202007899QA SG11202007899QA (en) 2018-02-27 2019-02-27 Ultra-sensitive detection of circulating tumor dna through genome-wide integration

Country Status (10)

Country Link
US (1) US20210043275A1 (en)
EP (1) EP3759237A4 (en)
JP (2) JP2021519607A (en)
KR (1) KR20210009299A (en)
CN (1) CN112601826A (en)
AU (1) AU2019229273B2 (en)
CA (1) CA3092343A1 (en)
IL (1) IL276891A (en)
SG (1) SG11202007899QA (en)
WO (1) WO2019169042A1 (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10395772B1 (en) * 2018-10-17 2019-08-27 Tempus Labs Mobile supplementation, extraction, and analysis of health records
WO2020142558A1 (en) * 2018-12-31 2020-07-09 Tempus Labs Automated quality assurance testing of structured clinical data
US20200340064A1 (en) * 2019-04-16 2020-10-29 Grail, Inc. Systems and methods for tumor fraction estimation from small variants
EP4004238A1 (en) * 2019-07-23 2022-06-01 Grail, LLC Systems and methods for determining tumor fraction
WO2021046461A1 (en) * 2019-09-05 2021-03-11 Fabric Genomics, Inc. Methods of analyzing genetic variants based on genetic material
CN110659599A (en) * 2019-09-19 2020-01-07 安徽七天教育科技有限公司 Scanning test paper-based offline handwriting authentication system and using method thereof
CN110808081B (en) * 2019-09-29 2022-07-08 深圳吉因加医学检验实验室 Model construction method for identifying tumor purity sample and application
JP2022516092A (en) * 2019-10-08 2022-02-24 イルミナ インコーポレイテッド Fragment size characterization of cell-free DNA mutations from clonal hematopoies
EP4045915A4 (en) * 2019-10-16 2023-11-15 Icahn School of Medicine at Mount Sinai Systems and methods for detecting a disease condition
CN110890132A (en) * 2019-11-19 2020-03-17 湖南大学 Cancer mutation cluster identification method based on adaptive Gaussian mixture model
WO2021144578A1 (en) * 2020-01-16 2021-07-22 Congenica Ltd. Application of pathogenicity model and training thereof
CN111310680B (en) * 2020-02-24 2022-11-04 电子科技大学 Radiation source individual identification method based on deep learning
JP2023517029A (en) * 2020-03-11 2023-04-21 ガーダント ヘルス， インコーポレイテッド Methods for Classifying Genetic Mutations Detected in Cell-Free Nucleic Acids as Tumor or Non-Tumor Origin
CN111341383B (en) * 2020-03-17 2021-06-29 安吉康尔（深圳）科技有限公司 Method, device and storage medium for detecting copy number variation
US11545250B2 (en) * 2020-03-20 2023-01-03 Kpn Innovations, Llc. Methods and systems for generating lifestyle change recommendations based on biological extractions
KR102309277B1 (en) * 2020-03-26 2021-10-07 주식회사 클리노믹스 Method for providing genetic test service using one or more genetic and epigenetic markers and their patterns for target species that are originated from one or more genetic and epigenetic markers of one or more model species based on matching between different species
AU2021283380A1 (en) 2020-06-03 2023-01-05 Alexis Bio, Inc. Selection and monitoring methods for xenotransplantation
WO2021262770A1 (en) * 2020-06-22 2021-12-30 Children's Hospital Medical Center De novo characterization of cell-free dna fragmentation hotspots in healthy and early-stage cancers
CA3189109A1 (en) * 2020-08-18 2022-02-24 Jacob CAREY Methods and systems for cell-free dna fragment size densities to assess cancer
CN112285565B (en) * 2020-09-21 2021-07-13 电子科技大学 Method for predicting SOH (State of health) of battery by transfer learning based on RKHS (remote keyless entry) domain matching
WO2022168195A1 (en) * 2021-02-03 2022-08-11 国立大学法人東北大学 Genetic information analysis system and genetic information analysis method
CA3208715A1 (en) * 2021-02-19 2022-08-25 Shelly Marie Sorrells Longitudinal molecular diagnostics detect somatic reversion mutations
CN113113085B (en) * 2021-03-15 2022-08-19 杭州杰毅生物技术有限公司 Analysis system and method for tumor detection based on intelligent metagenome sequencing data
CN112951418B (en) * 2021-05-17 2021-08-06 臻和(北京)生物科技有限公司 Method and device for evaluating methylation of linked regions based on liquid biopsy, terminal equipment and storage medium
CN113496762B (en) * 2021-05-20 2022-09-27 山东大学 Biological gene sequence summary data generation method and system
CN113257350B (en) * 2021-06-10 2021-10-08 臻和(北京)生物科技有限公司 ctDNA mutation degree analysis method and device based on liquid biopsy and ctDNA performance analysis device
CN113096728B (en) * 2021-06-10 2021-08-20 臻和(北京)生物科技有限公司 Method, device, storage medium and equipment for detecting tiny residual focus
CN113362894A (en) * 2021-06-15 2021-09-07 上海基绪康生物科技有限公司 Method for predicting syndromal cancer driver gene
CN113470746B (en) * 2021-06-21 2023-11-21 广州市金域转化医学研究院有限公司 Method for reducing artificially introduced error mutation in high-throughput sequencing and application thereof
WO2022271159A1 (en) * 2021-06-22 2022-12-29 Foundation Medicine, Inc. Systems and methods for evaluating tumor fraction
CN113539355B (en) * 2021-07-15 2022-11-25 云康信息科技(上海)有限公司 Tissue-specific source for predicting cfDNA (deoxyribonucleic acid), related disease probability evaluation system and application
WO2023018791A1 (en) * 2021-08-10 2023-02-16 Cornell University Ultra-sensitive liquid biopsy through deep learning empowered whole genome sequencing of plasma
EP4392781A1 (en) * 2021-08-25 2024-07-03 XGenomes Corp. Random epigenomic sampling
CN113903398A (en) * 2021-09-08 2022-01-07 南京世和基因生物技术股份有限公司 Intestinal cancer early-screening marker, detection method, detection device, and computer-readable medium
WO2023043914A1 (en) * 2021-09-15 2023-03-23 The Broad Institute, Inc. Diagnosis and prognosis of richter's syndrome
CN113903401B (en) * 2021-12-10 2022-04-08 臻和(北京)生物科技有限公司 ctDNA length-based analysis method and system
CN114613432A (en) * 2021-12-14 2022-06-10 中国科学院动物研究所 Method and system for discovering molecular marker based on genome rare mutation load change and gene function association
WO2023133093A1 (en) * 2022-01-04 2023-07-13 Cornell University Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring
CN114446386B (en) * 2022-01-17 2024-02-02 中国人民解放军国防科技大学 Method for detecting ctDNA of blood
KR20230172174A (en) * 2022-06-15 2023-12-22 주식회사 지씨지놈 Method for diagnosing and predicting cancer type based on single nucleotide variant in cell-free DNA
US20240021267A1 (en) * 2022-07-18 2024-01-18 Grail, Llc Dynamically selecting sequencing subregions for cancer classification
WO2024047179A1 (en) * 2022-08-31 2024-03-07 Saga Diagnostics Ab Structural variant identification
CN117551767A (en) * 2022-09-29 2024-02-13 南京医科大学 Application of cfDNA fragment characteristic combination in prediction of cancer
CN115294231B (en) * 2022-09-29 2023-02-03 浙江省肿瘤医院 Method for predicting mismatch repair gene defect of gastric cancer
WO2024086515A1 (en) * 2022-10-17 2024-04-25 Foundation Medicine, Inc. Methods and systems for predicting a cutaneous primary disease site
WO2024091545A1 (en) * 2022-10-25 2024-05-02 Cornell University Nucleic acid error suppression
WO2024089689A1 (en) * 2022-10-25 2024-05-02 Clonal Ltd Methods for detection of breast cancer
CN115406815B (en) * 2022-11-02 2023-02-03 杭州华得森生物技术有限公司 Tumor cell detection equipment and method based on multi-source data fusion
WO2024118594A1 (en) * 2022-11-29 2024-06-06 Foundation Medicine, Inc. Methods and systems for mutation signature attribution
CN115595371B (en) * 2022-12-07 2023-04-11 元码基因科技（北京）股份有限公司 Method for determining MSI state of colorectal cancer patient and application
CN115690109B (en) * 2023-01-04 2023-03-14 杭州华得森生物技术有限公司 Tumor cell detection device based on computational organisms and method thereof
CN116386903B (en) * 2023-06-06 2023-11-10 中国医学科学院肿瘤医院 Method for reading heterogeneity between tumors and in tumors of small cell lung cancer
CN116863998B (en) * 2023-06-21 2024-04-05 扬州大学 Genetic algorithm-based whole genome prediction method and application thereof
CN116895332B (en) * 2023-09-11 2023-12-05 臻和(北京)生物科技有限公司 Filtering method for interrupting false positive mutation generated by artificial fragments in library construction by enzyme digestion method
CN117253546B (en) * 2023-10-11 2024-05-28 北京博奥医学检验所有限公司 Method, system and storable medium for reducing targeted second-generation sequencing background noise
CN117373678B (en) * 2023-12-08 2024-03-05 北京望石智慧科技有限公司 Disease risk prediction model construction method and analysis method based on mutation signature
CN117976045B (en) * 2024-03-29 2024-06-14 鲁东大学 Gene mutation data-based cancer metastasis related gene prediction method

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10236078B2 (en) * 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
EP2891099A4 (en) * 2012-08-28 2016-04-20 Broad Inst Inc Detecting variants in sequencing data and benchmarking
EP3240911B1 (en) * 2014-12-31 2020-08-26 Guardant Health, Inc. Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
US10815522B2 (en) * 2015-02-20 2020-10-27 The Johns Hopkins University Genomic alterations in the tumor and circulation of pancreatic cancer patients
US10364468B2 (en) * 2016-01-13 2019-07-30 Seven Bridges Genomics Inc. Systems and methods for analyzing circulating tumor DNA
US10095831B2 (en) * 2016-02-03 2018-10-09 Verinata Health, Inc. Using cell-free DNA fragment size to determine copy number variations
US11479878B2 (en) * 2016-03-16 2022-10-25 Dana-Farber Cancer Institute, Inc. Methods for genome characterization
GB201607629D0 (en) * 2016-05-01 2016-06-15 Genome Res Ltd Mutational signatures in cancer
WO2017201497A1 (en) * 2016-05-19 2017-11-23 Oncoscar Llc Methods of diagnosis and therapeutic targeting of clinically intractable malignant tumors
CN107447258A (en) * 2016-06-01 2017-12-08 大连医科大学 Circulating tumor DNA target gene high flux detects library and its detection method and application
CN105950750A (en) * 2016-06-08 2016-09-21 福州市传染病医院 Genetic group and kit for liver cancer diagnosis and prognosis evaluation

Also Published As

Publication number Publication date
WO2019169042A1 (en) 2019-09-06
EP3759237A4 (en) 2022-06-01
JP2024019413A (en) 2024-02-09
AU2019229273A1 (en) 2020-09-10
US20210043275A1 (en) 2021-02-11
AU2019229273B2 (en) 2023-04-27
IL276891A (en) 2020-10-29
JP2021519607A (en) 2021-08-12
CA3092343A1 (en) 2019-09-06
CN112601826A (en) 2021-04-02
EP3759237A1 (en) 2021-01-06
KR20210009299A (en) 2021-01-26

Similar Documents

Publication Publication Date Title
IL276891A (en) Ultra-sensitive detection of circulating tumor dna through genome-wide integration
HK1243764A1 (en) Method for the enrichment of circulating tumor dna
ZA201804322B (en) Deep sequencing profiling of tumors
PL3259598T3 (en) Multifunctional magneto-polymeric nanosystems for rapid targeting, isolation, detection and simultaneous imaging of circulating tumor cells
IL255714B (en) Detection of target nucleic acid and variants
IL254687B1 (en) Biosensor system for the rapid detection of analytes
GB2571026B (en) Detection of PH
IL280603A (en) In vitro detection of nucleic acid
SG11202112523UA (en) Detection of colorectal cancer
SG11202112522TA (en) Detection of colorectal cancer
SG10201912967YA (en) Determination of nucleic acid methylation
EP3094767A4 (en) Use of nucleic acid agents for ultra-sensitive digital detection and quantification of target molecules
EP3562961A4 (en) Compositions and methods for detecting circulating tumor dna
IL269315A (en) Detection, quantification and/or isolation of circulating tumor cells based on the expression of cd321 marker
GB201602210D0 (en) Detection of cancer
EP3100053A4 (en) Methods for the detection and quantification of circulating tumor cell mimics
IL255081A0 (en) Detection of nucleic acid molecules
EP3286339A4 (en) Oligonucleotide-based probes for detection of circulating tumor cell nucleases
GB201905861D0 (en) Methods of detecting cancer
EP3183366A4 (en) Systems and methods of detecting solid tumor cancer
IL281037A (en) Methods of detecting nucleic acid
HK1246851A1 (en) Methods of detecting cancer
GB201908085D0 (en) Methods of determining cancer
GB2552535B (en) Detection of scatter radiation
GB201818965D0 (en) Method for the detection of colorectal cancer